Structure Therapeutics Inc. (GPCR) Free cash flow 2022–2025
Structure Therapeutics Inc. (GPCR) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$225.8MFY2025 · since FY2022: -$46.3M → -$225.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$225.8M | -91.5% |
| FY2024 | -$117.9M | -44.4% |
| FY2023 | -$81.7M | -76.5% |
| FY2022 | -$46.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More GPCR financial trends
GPCR RevenueGPCR Net incomeGPCR Net marginGPCR Gross profitGPCR Gross marginGPCR Operating incomeGPCR Operating marginGPCR Operating cash flowGPCR Capital expendituresGPCR Return on equityGPCR Stock buybacksGPCR Dividends paidGPCR Total assetsGPCR Total liabilitiesGPCR Shareholders’ equityGPCR overview →